Lisl J. Dunlop Law Firm Steering Committee Axinn Veltrop & Harkrider (New York)


Lisl Dunlop is a partner at Axinn in New York. She represents clients in a broad range of industries in antitrust matters before the federal courts and the antitrust enforcement agencies. Ms. Dunlop advises and represents clients in civil merger and non-merger investigations by the Department of Justice and Federal Trade Commission, appearing before both agencies regularly. Recent transactions include Ardagh’s acquisition of Saint-Gobain Containers, Synthes’ acquisition by Johnson & Johnson, Psychiatric Solutions’ acquisition by Universal Health, Dun & Bradstreet’s acquisition of QED, and Ciba’s acquisition by BASF. She also coordinates the multijurisdictional antitrust defense of cross-border transactions. In addition, Ms. Dunlop has represented clients in antitrust class actions under Sections 1 and 2 of the Sherman Act and has advised and represented a number of clients in criminal antitrust enforcement actions in the U.S. and elsewhere. Ms. Dunlop has practiced as a competition lawyer in a number of jurisdictions: she commenced her career at Allen Allen & Hemsley in Sydney, and worked in the London office of Shearman & Sterling in 2001-2002. Ms. Dunlop is admitted to the bars of New York, the District of Columbia, England, and New South Wales, Australia. She is active in the Antitrust and International Sections of the American Bar Association, and the Antitrust Section of the New York State Bar Association, and is a frequent speaker and writer on current antitrust issues. Specialties: Antitrust counseling in M&A, joint ventures and general business activities; cartel defense; antitrust litigation.

2021 Compliance

Send a message